TRAF3 and diffuse large B-cell lymphoma: However, in the presence of BCG-induced chronic inflammation, the transplanted DLBCL cells developed into tumors in 25% of LMC mice and almost all (91.7%) of the examined M-Traf3-/- mice, leading to significantly shortened survival of the knockout recipients (Figures 2A–C).